Patents by Inventor Fionn Susannah O'Hara

Fionn Susannah O'Hara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS
    Publication number: 20250099448
    Abstract: The invention provides new heterocyclic compounds having the general formula (I) wherein A and R1 to R4 are as described heroin, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
    Type: Application
    Filed: January 25, 2023
    Publication date: March 27, 2025
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Machoud AMOUSSA, Joerg BENZ, Julie Elisabeth Francoise BLAISING, Jason Jacques DENIZOT, Kallie FRISTON, Rudolf Liun Zaccaria GANZONI, Maude GIROUD, Uwe GRETHER, Benoit HORNSPERGER, Isabelle KAUFMANN, Bernd KUHN, Camiel John LEAKE, Jacopo MARGARINI, Rainer Eugen MARTIN, Fionn Susannah O'HARA, Bernd PUELLMANN, Martin RITTER, Didier ROMBACH, Valerie RUNTZ-SCHMITT, Philipp Claudio SCHMID, Matthias Beat WITTWER
  • BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS
    Publication number: 20250059185
    Abstract: The invention provides new MAGL inhibitors having the general formula (II)AB(II) wherein the variables are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 20, 2025
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Joerg BENZ, Maude GIROUD, Uwe GRETHER, Bernd KUHN, Fionn Susannah O'HARA, Matthias Beat WITTWER
  • NEW THIAZOLOPYRIMIDINONE DERIVATIVES
    Publication number: 20240018163
    Abstract: The invention relates to a compound of formula (I) wherein R1—R4 and A1-A3 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 18, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Virginie BROM, Cosimo DOLENTE, Delphine GAUFRETEAU, Nadine GRETHER, Fionn Susannah O'HARA, Matilde PIRAS, Hasane RATNI, Michael REUTLINGER, Walter VIFIAN, Claudio ZAMBALDO
  • NEW THIADIAZOLOPYRIMIDONE DERIVATIVES
    Publication number: 20240010659
    Abstract: The invention relates to a compound of formula (I) wherein R1-R4 and A1 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 11, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Cosimo DOLENTE, Nadine GRETHER, Fionn Susannah O'HARA, Matilde PIRAS, Hasane RATNI, Michael REUTLINGER, Walter VIFIAN, Claudio ZAMBALDO
  • THIENOPYRIMIDINONE DERIVATIVES
    Publication number: 20240002407
    Abstract: The invention relates to a compound of formula (I) wherein X, R1-R4 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Cosimo DOLENTE, Nadine GRETHER, Fionn Susannah O'HARA, Matilde PIRAS, Hasane RATNI, Michael REUTLINGER, Walter VIFIAN, Claudio ZAMBALDO
  • KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS
    Publication number: 20230124087
    Abstract: The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L, Y1 to Y4 and R1 to R6 are as described herein.
    Type: Application
    Filed: October 21, 2022
    Publication date: April 20, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Anja Gundlfinger, Benjamin John Hall, Markus Robert Hierl, Frédéric Knoflach, Fionn Susannah O'Hara, Hasane Ratni, Roger Lluis Redondo, Michael Robert Reutlinger, Didier Rombach